AANP and AAPA Presidents discuss how elimination of the X-Waiver and patient caps for buprenorphine prescription for opioid use disorder will affect clinical practice.
The number of US health care providers certified to prescribe buprenorphine more than doubled in the past 4 years, and treatment advocates hope to see that trend continue.
A study sought to determine if mindfulness-based stress reduction would ease compassion fatigue and burnout among the facility’s pediatric oncology nurses.
Liver disease and cirrhosis now outpace diabetes and stroke as the leading cause of mortality in people aged 25 to 54 years. New survey results shows shortfalls in adoption of national treatment guidelines for liver disease and cirrhosis.
Study finds that medication administration processes (MAPs) are frequently interrupted and these disruptions may create an opportunity for patient harm.